glp-1 shortage weight loss drugs leave users low on key nutrients, study finds GLP-1s Going Direct, How Novo

It is also important to contact your healthcare provider if heartburn symptoms significantly impact quality of life or medication adherence

Clinical studies show equivalent efficacy and tolerability, with additional advantages of flexible dosing, lower cost, and faster access without insurance delays

Key highlights: Once-daily oral administration No food or water restrictions No injections required ~12% mean weight loss in Phase 3 trials Improvements in cardiometabolic risk markers Indication: Approved for adults with obesity, or overweight individuals with weight-related comorbidities, alongside reduced-calorie diet and increased physical activity

doi: 10.1177/2515690X20916123 209 ChackrewarthySThabrewMIWeerasuriyaMKBJayasekeraS

Oral Semaglutide in Type 2 Diabetes: ClinicalMetabolic Outcomes and Quality of Life in Real-World Practice

, HecksherSoerensen, J